The Pharmaceutical Amino Acid Market was valued at USD 27.5 billion in 2023 and is projected to reach a market size of USD 50.27 Billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 9%.
Pharmaceutical amino acids are a class of chemical substances that are vital components of proteins and are involved in many biological processes in the human body. The pharmaceutical industry uses these amino acids extensively for the manufacture of medications, parenteral nutrition, and nutritional supplements. Amino acids are organic substances that are safe to employ in medicinal settings.
Key Market Insights
The growing demand for supplements and pharmaceuticals containing amino acids is driving significant growth in the pharmaceutical amino acid industry. The creation of novel amino acid-based medications and treatments has resulted from improvements in biotechnology and pharmaceutical manufacturing techniques, which has further fueled market expansion.
The market is expanding due to factors such as rising healthcare costs, rising knowledge of the role amino acids play in managing diseases, and an aging population. The market is growing as a result of the rising incidence of chronic illnesses and the demand for customized treatment. Plant-based protein sources are becoming more and more necessary these days because veganism and vegetarianism are becoming more and more popular. Because plant-based proteins often lack one or more essential amino acids, amino acid supplements are used to ensure that those following plant-based diets receive the appropriate amount of nutrition.
The introduction of innovative amino acid formulations and combination therapies to improve medication efficacy and minimize side effects are among the most recent developments in the pharmaceutical amino acid market. Because of their greater efficacy and purity, natural amino acids derived from plant and microbial fermentation methods are becoming increasingly popular, as seen by the market.
Pharmaceuticals Amino Acid market drivers:
The market is growing as a result of the rising incidence of chronic illnesses and the demand for customized treatment.
All living organisms use amino acids as building blocks to create proteins. Twenty distinct amino acids are necessary for your body to function properly. Although the human body produces hundreds of amino acids, it is unable to produce nine of the essential amino acids.
We refer to these as essential amino acids. They have to come from the food people consume. The usage of amino acids in supplements and medications has increased dramatically due to people's deteriorating physical and medical conditions, which necessitates outside help even in situations where the body can synthesize amino acids on its own without outside assistance.
Novel amino acid-based medications and treatments have been developed as a result of developments in biotechnology and pharmaceutical production techniques.
Amino acids contribute to the improvement of medical nutrition products' dependability, quality, and safety. These amino acids offer an effective way to obtain the necessary nutrients for parenteral, enteral, and newborn nutrition. To safeguard, support, or improve the stability and bioavailability of an API, amino acids can also be added to pharmaceuticals. They can also facilitate the definition of a release profile, enhance patient acceptance, and support medication manufacturing.
According to Ambreen et al., 2021, Brunton et al., 2006, Jafari et al., 2021, and Kozma et al., 2016, oral absorption, formulation, and/or bioavailability issues are linked to the low water solubility of certain medications, which is one of the largest obstacles facing the pharmaceutical business. Here, combining medications with highly water-soluble molecules—like AA—represents a potential workaround for the issues associated with poorly soluble pharmaceuticals.
The market is developing due to rising healthcare costs, rising knowledge of the role amino acids play in managing diseases, and expanding geriatric population.
The amino acids aid in the breakdown of food, develop and repair bodily tissue, manufacture neurotransmitters, brain chemicals, and hormones, a source of energy is provided, Keep the nails, skin, and hair healthy, and Build muscle. It also establishes a stronger immune system and maintains a healthy digestive system. People would choose to be safe and save money by consuming different foods that contain amino acids rather than risk contracting an expensive illness that would necessitate more out-of-pocket healthcare expenditures. Such proteins are also essential for the smooth operation of the aging population, which is predicted to be growing.
Amino acids (AA) have gained increasing interest in delivery systems research due to their beneficial characteristics fuelling market demand.
The combination of appropriate molecules is one of the promising approaches in drug delivery system development that is of interest. The ideal structural characteristics of AA, which include side chains, an α-amino group, and α-carboxylate, are ideal for forming drug linkages. As a result, the AA can create a variety of ionic, hydrophobic, and/or hydrogen bonding interactions between molecules (Tilburg et al., 2014). According to Kamei et al. (2017), AA are alternative excipients that have a low molecular weight and bind to the medications' biological receptors. As a result, AA is a useful co-former that can serve as a novel foundation for medication formulations with improved qualities.
The study and creation of medication delivery systems have advanced quickly in the last several years, especially in the domains of distribution routes, transport vehicles, and targeted tactics. When delivering drugs, the target may include entire organs, specific tissue, disease-specific structures, or internal cell structures. Thanks to their advantageous properties, amino acids (AA) have recently attracted more attention in delivery systems research.
Pharmaceuticals Amino Acid Market Restraints and Challenges:
Several issues, such as price volatility, regulatory compliance, side effects, alternative sources, competition from replacements, and low consumer knowledge, could hinder the growth and development of the amino acid industry.
While producers may incur significant costs and time in complying with regulations, the pricing of amino acids is susceptible to swings due to other variables. Certain amino acids have unfavorable side effects when taken in high concentrations, which restricts their application in specific industries. As an alternative to animal-derived amino acids, which may threaten supply, plant-based proteins are more affordable and environmentally friendly. Market expansion may be constrained by stiff competition from alternatives like proteins, peptides, and other supplements that provide comparable advantages. Notwithstanding these obstacles, creativity, technical development, and strict quality control procedures can assist in overcoming these limitations and guaranteeing the usefulness and safety of amino acid products.
The price of raw materials used to produce amino acids, such as corn, wheat, and soybean oilseeds, has fluctuated recently. Due to the limited availability of raw materials for the manufacturing of other foods, which is driving up demand for these resources, it is anticipated that this trend will persist during the projected period. Other obstacles causing a shortage of raw materials for the manufacturing of amino acids include short-term variables like rising energy prices. Manufacturers in developing economies are frequently compelled to produce amino acids using inferior substitute sources like sorghum or cassava.
Pharmaceutical Amino Acid Market Opportunities:
Emerging economies with expanding healthcare facilities and rising disposable income would present substantial development potential for the market. Ongoing research and development initiatives aimed at extending the uses of amino acids in medication creation are also anticipated to be beneficial to the market.
In addition, innovative amino acid formulations and combination therapies to improve medication efficacy and lessen side effects are among the most recent developments in the pharmaceutical amino acid market. An increasing inclination towards natural amino acids obtained from microbial and plant fermentation methods is also evident in the market, due to the higher efficacy and purity of these sources. The market for pharmaceutical amino acids is expected to develop significantly in the upcoming years due to several factors, including rising healthcare costs, improvements in pharmaceutical production techniques, and growing awareness of the role that amino acids play in illness management. Pharmaceutical amino acids should continue to see new developments and increased uses in the market as a result of ongoing research and development initiatives.
PHARMACEUTICAL AMINO ACID MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023- 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
9% |
|
Segments Covered |
By source, Type, Component, application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Ajinomoto Co., Inc., KYOWA HAKKO BIO CO., LTD., AMINO GmbH, Bill Barr & Company, IRIS BIOTECH GMBH, BI Nutraceuticals |
Plant-based Amino acid
Animal-based Amino acid
Chemical synthesis
With a revenue share of 43.7% in 2023, the plant-based in-source category led the market. The increasing awareness of natural and organic products among consumers is credited with this growth. Plants such as soybeans, wheat, corn, potatoes, and peas are the source of the product. Due to their widespread worldwide production and use, soybeans are being employed as a commercial source of amino acids. However, it is well recognized that processing soybeans modifies the product's composition, which raises serious concerns when attempting to obtain amino acids from them. On the other hand, the increased global demand for plant-derived products is anticipated to benefit from the increased social awareness around animal slaughter. Although animal proteins are more easily digested than those derived from plants.
Another market that is expected to expand throughout the projection period is chemical synthesis. A biological mechanism is responsible for producing the majority of amino acids. The majority of the product is created via a synthetic process that starts with α-ketoacids and ends with transamination using another amino acid, usually glutamate. An enzyme called an aminotransferase is responsible for facilitating this transition. In turn, the amination of α-ketoglutarate results in the production of glutamate. Additionally, the substance is produced commercially using mutant microorganisms.
Essential amino acid
Non-essential amino acid
With a revenue share of 52.6% in 2023, the non-essential type category led the market. Their widespread usage in animal feed to give the animals a balanced amino acid profile is the reason behind this. Diets are designed by animal nutritionists to satisfy the dietary demands of animals, especially their protein requirements. Since proteins are composed of amino acids, the animal's diet must have a balanced combination of necessary and non-essential items. This promotes the best possible development, growth, and health. Around the world, the use of essential type segments is also steadily increasing due to factors like the aging population, growing awareness, and the surge in demand for sports nutrition products and dietary supplements. Conditional amino acids include several non-essential amino acids. This implies that they are only deemed necessary when you're sick or under stress. The amino acids arginine, cysteine, glutamine, tyrosine, glycine, ornithine, proline, and serine are conditional.
Lysine
Glutamic acid
Valine
Leucine
Isoleucine
Glutamic Acid in the non-essential segment dominated the market with a revenue share of 42.3% in 2023. It is also involved in the production of energy and is an important neurotransmitter in the brain. It plays a role in the regulation of neurotransmitters in the brain, and it also has neuroprotective effects. Over the course of the projection period, growth is also expected for lysine in the essential type category. The global market expansion for dietary supplements is the primary factor driving the demand for lysine. In addition to being consumed by humans, this is a common addition to animal feed. It is widely employed in the body's protein deposition process. The amount of lysine that an animal consumes daily affects its growth. Animal growth and feed quality are improved by changing the dietary lysine concentration in animal feed. Over the course of the projection period, it is anticipated that the global demand for lysine will increase due to the growing need for protein from animal feed manufacturers as well as the rising usage of dietary supplements.
Health-care products
Medicine
Others
Pharmaceutical amino acids are used in a wide range of industries. They are utilized in the production of functional meals and nutritional supplements for the healthcare products industry, which advances general health and wellness. In the medical industry, they are utilized in the formulation of pharmaceuticals and medications for the treatment of various illnesses and ailments. Furthermore, they are used in other markets for the manufacturing of animal feed, cosmetics, and a variety of industrial applications like biotechnology and agriculture due to their adaptability. Pharmaceutical amino acids are used in these markets, which emphasizes their importance and broad reach. In 2023, the amino acid market was dominated by the pharma-grade category, which held a 39.1% revenue share. The reason for this growth is that pharmaceutical grades are among the most expensive and premium grades of these acids. Strict quality control procedures are used during manufacturing to guarantee the products' safety and purity. They are essential for many biological functions carried out by the human body, including the synthesis of proteins, cell signaling, and neurotransmitter production.
North America
Asia-Pacific
Europe
South America
Middle East and Africa
The market for pharmaceutical amino acids is anticipated to expand significantly in several regions, including China, North America, Europe, Asia Pacific (APAC), and the United States (USA). With a revenue share of 46.1% in 2023, Asia Pacific led the market. It's anticipated that China's growing hog consumption will propel market expansion there. The demand for amino acids is predicted to increase in China as a result of growing health concerns and rising personal medical costs. These factors are also likely to drive China's demand for dietary supplements. North America is anticipated to lead the global market. Factors contributing to the region's supremacy include the existence of well-established pharmaceutical corporations and rising R&D expenditures. In North America, the need for pharmaceutical amino acids is driven by strict regulatory requirements and the rising incidence of chronic illnesses. It is anticipated that this region will have a substantial market share valuation; however, precise numbers cannot be given without a comprehensive market analysis. In terms of dominance and market share percentage valuation, North America is expected to lead the pharmaceutical amino acids market. North America commanded the greatest market share in 2020, and the region's market is anticipated to grow more slowly than Asia's. The increasing usage of amino acid analyzers in food quality testing, drug discovery research, and raising public health awareness are the main factors driving the market's expansion in North America.
COVID-19 Impact Analysis on the Pharmaceutical Amino Acid Market:
The amino acid market was very stable during the whole duration of the pandemic one of the reasons was amino acid is a natural ingredient and it is induced in essential products and is still working such as agriculture, pharma, and others, which kept the market in good shape. The market faced certain challenges during the COVID-19 epidemic due to supply chain disruptions brought on by the mandatory shutdown of manufacturing sectors. This resulted in unstable supply and demand for products containing these proteins. The market for products containing amino acids increased as a result of people seeking therapies that increased protection as the virus spread. A surge in the demand for foods, medications, and health supplements that boost immunity as a preventative measure as well as a therapeutic intervention was observed during the COVID-19 pandemic. Through various pathways, the amount of necessary and conditional amino acids increased.
Latest Trends/ Developments:
Ambition, the first-ever amino acid biostimulant, was launched by Bayer AG in China in January 2022. The object promotes photosynthesis and the growth of plants. Ambition helps crops reach their maximum potential by enhancing plant defenses, controlling nutrient efficiency, and enhancing crop output.
CJ Chilean Corp. announced the release of Flavor-rich Master C in April 2021. This is the world's first naturally occurring cysteine, satisfying consumer desire for transparent, natural flavorings derived from plants. This has helped the company expand the range of products it offers.
Key Players:
The number of companies active in the worldwide product market is significant, which leads to the industry being deemed fragmented. Market share is maximized by leaders and other emerging players in the nation, such as small manufacturers, dealers, and participants at the local level. To keep their place in the market, businesses are expanding and introducing new products. Several well-known companies in the amino acid market are:
Ajinomoto Co., Inc.
KYOWA HAKKO BIO CO., LTD.
AMINO GmbH
Bill Barr & Company
IRIS BIOTECH GMBH
BI Nutraceuticals
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Pharmaceutical Amino Acid Market was valued at USD 27.5 billion in 2023.
The market is projected to grow at a CAGR of 9%.
The market is growing as a result of the rising incidence of chronic illnesses and the demand for customized treatment, developments in biotechnology and pharmaceutical production techniques rising healthcare costs, rising knowledge of the role amino acids play in managing diseases, and expanding geriatric population.
The key players are Ajinomoto Co., Inc., KYOWA HAKKO BIO CO., LTD, AMINO GmbH, Bill Barr & Company, and IRIS BIOTECH GMBH.
Several issues, such as price volatility, regulatory compliance, side effects, alternative sources, competition from replacements, and low consumer knowledge, could hinder the growth and development of the amino acid industry.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
